Clinical Trial Update: Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating symptom response to a menthol-containing eyedrop (Rohto Hydra) in normal and dry eye patients; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Rohto Hydra

Snippet

Sponsor: ORA, Inc. | Conditions: Dry Eye | Phase 4 | Status: COMPLETED | Results posted: 2018-12-19